Enoticumab (Anti-DLL4) (A2848-GRP)

Enoticumab (Anti-DLL4) is a human monoclonal antibody directed against Delta-like ligand-4 (DLL4) with potential antineoplastic activity.It has been used to treat  advanced solid tumors MW : 146.48 KD.